|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print May 16, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00097.2002
Submitted on February 6, 2002
Accepted on May 13, 2002
KPQ
1 Nora Eccles Harrison CVRTI, University of Utah, Salt Lake City, Utah, USA
* To whom correspondence should be addressed. E-mail: michael{at}cvrti.utah.edu.
KPQ, a three amino acid deletion mutation of the human cardiac Na channel (hH1) that is one cause of LQT3, has impaired inactivation resulting in a late sodium current. To better understand inactivation in
KPQ we applied a site-3 toxin, Anthopleurin A, that has been shown to inhibit inactivation from the open state with little or no effect on inactivation from the closed state(s) in wild-type hH1. In contrast to the effect of site-3 toxins on wild-type hH1, inactivation from closed state(s) in toxin-modified
KPQ demonstrated a large negative shift in the Na channel availability curve of nearly -14 mV. Recovery from inactivation showed that toxin-modified
KPQ channels recovered slightly faster than those in control, while development of inactivation at potentials negative to -80 mV showed that inactivation developed much more rapidly in toxin-modified
KPQ channels compared to control. An explanation for our results is that closed-state inactivation in toxin- modified
KPQ is enhanced by the mutated inactivation lid being positioned "closer" to its receptor resulting in an increased rate of association between the inactivation lid and its receptor.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |